Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.0200 (-0.81%) ($11.0200 - $11.0200) on Wed. Dec. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 59 | Latest Price | $11.0200(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.5% a day on average for past five trading days. | Weekly Trend | FOLD advances 1.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(71%) XBI(68%) XLB(68%) VT(67%) XLF(67%) | Factors Impacting FOLD price | FOLD will decline at least -1.69% in a week (0% probabilities). UUP(-11%) URA(-10%) XLE(-8%) TBT(1%) USO(9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.09(-0.63%) | 10 Day Moving Average | $10.87(1.38%) | 20 Day Moving Average | $10.77(2.32%) | To recent high | -17.4% | To recent low | 10.6% | Market Cap | $2.846b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |